Simultaneous detection of single‐nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA‐based next‐generation sequencing assay

Simultaneous detection of single‐nucleotide variant, deletion/insertion, and fusion in lung and... INTRODUCTIONMolecular testing for epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) and ROS proto‐oncogene 1, receptor tyrosine kinase (ROS1) fusion is routinely performed in patients with stage IV lung adenocarcinoma to assess their eligibility for targeted therapy. The current guideline from the College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC), and Association for Molecular Pathology (AMP) recommends that patients should be tested regardless of age, race, and smoking history. Fine‐needle aspiration (FNA) is commonly considered as the first diagnostic procedure and FNA‐derived material is frequently the only pathologic material available for morphologic diagnosis, immunohistochemistry, and molecular studies. It is especially in these instances that cytology material becomes extremely valuable for patient management.Likewise, in patients with thyroid nodules, FNA is an integral part of the clinical assessment as defined by the American Thyroid Association guidelines due to its high sensitivity and specificity. Although the diagnosis and management of benign and malignant nodules usually is not problematic, nodules classified as follicular lesions of undetermined significance/atypia of undetermined significance (FLUS/AUS; Bethesda category III are challenging for both the cytopathologist and clinician. Approximately one‐third of the FNA specimens in the suspicious for follicular neoplasm http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Cytopathology Wiley

Simultaneous detection of single‐nucleotide variant, deletion/insertion, and fusion in lung and thyroid carcinoma using cytology specimen and an RNA‐based next‐generation sequencing assay

Loading next page...
 
/lp/wiley/simultaneous-detection-of-single-nucleotide-variant-deletion-insertion-0c8eTtvjDJ
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 American Cancer Society
ISSN
1934-662X
eISSN
1934-6638
D.O.I.
10.1002/cncy.21963
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONMolecular testing for epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) and ROS proto‐oncogene 1, receptor tyrosine kinase (ROS1) fusion is routinely performed in patients with stage IV lung adenocarcinoma to assess their eligibility for targeted therapy. The current guideline from the College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC), and Association for Molecular Pathology (AMP) recommends that patients should be tested regardless of age, race, and smoking history. Fine‐needle aspiration (FNA) is commonly considered as the first diagnostic procedure and FNA‐derived material is frequently the only pathologic material available for morphologic diagnosis, immunohistochemistry, and molecular studies. It is especially in these instances that cytology material becomes extremely valuable for patient management.Likewise, in patients with thyroid nodules, FNA is an integral part of the clinical assessment as defined by the American Thyroid Association guidelines due to its high sensitivity and specificity. Although the diagnosis and management of benign and malignant nodules usually is not problematic, nodules classified as follicular lesions of undetermined significance/atypia of undetermined significance (FLUS/AUS; Bethesda category III are challenging for both the cytopathologist and clinician. Approximately one‐third of the FNA specimens in the suspicious for follicular neoplasm

Journal

Cancer CytopathologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off